
Axsome to narrow focus of depression drug trial after limited success in initial run
Audio By Carbonatix (Reuters) -Axsome Therapeutics said on Tuesday it will narrow the focus of a late-stage study of its depression drug after an initial run of the trial showed improvement only in a small subgroup of patients. The drug, solriamfetol, did …